Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Reactive arthritis after COVID-19.
Hønge BL, Hermansen MF, Storgaard M. Hønge BL, et al. Among authors: hermansen mf. BMJ Case Rep. 2021 Mar 2;14(3):e241375. doi: 10.1136/bcr-2020-241375. BMJ Case Rep. 2021. PMID: 33653867 Free PMC article.
Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases.
Troldborg A, Thomsen MK, Bartels LE, Andersen JB, Vils SR, Mistegaard CE, Johannsen AD, Hermansen MF, Mikkelsen S, Erikstrup C, Hauge EM, Ammitzbøll C. Troldborg A, et al. Among authors: hermansen mf. J Rheumatol. 2022 Jun;49(6):644-649. doi: 10.3899/jrheum.211152. Epub 2022 Mar 1. J Rheumatol. 2022. PMID: 35232803 Free article.
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour.
Ammitzbøll C, Thomsen MK, Andersen JB, Bartels LE, Hermansen MF, Johannsen AD, Mistegaard CE, Mikkelsen S, Vils SR, Erikstrup C, Hauge EM, Troldborg A. Ammitzbøll C, et al. Among authors: hermansen mf. Mod Rheumatol. 2023 Jul 4;33(4):777-785. doi: 10.1093/mr/roac069. Mod Rheumatol. 2023. PMID: 35860843 Free PMC article.
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
Bartels LE, Ammitzbøll C, Andersen JB, Vils SR, Mistegaard CE, Johannsen AD, Hermansen MF, Thomsen MK, Erikstrup C, Hauge EM, Troldborg A. Bartels LE, et al. Among authors: hermansen mf. Rheumatol Int. 2021 Nov;41(11):1925-1931. doi: 10.1007/s00296-021-04972-7. Epub 2021 Sep 2. Rheumatol Int. 2021. PMID: 34476603 Free PMC article.
Revaccination of patients with systemic lupus erythematosus or rheumatoid arthritis without an initial COVID-19 vaccine response elicits seroconversion in half of the patients.
Ammitzbøll C, Thomsen MK, Andersen JB, Jensen JMB, Bayarri-Olmos R, Garred P, Hermansen MF, Johannsen AD, Larsen ML, Mistegaard CE, Mikkelsen S, Nielsen L, Olesen R, Pérez-Alós L, Vils SR, Szabados F, Søgaard OS, Tolstrup M, Erikstrup C, Hauge EM, Troldborg A. Ammitzbøll C, et al. Among authors: hermansen mf. Clin Exp Rheumatol. 2024 Jan;42(1):157-165. doi: 10.55563/clinexprheumatol/orpp04. Epub 2023 Oct 23. Clin Exp Rheumatol. 2024. PMID: 37877429 Free article.